919 — Modern Healthcare Technology Holdings Income Statement
0.000.00%
- HK$94.97m
- -HK$67.70m
- HK$453.27m
- 57
- 99
- 24
- 67
Annual income statement for Modern Healthcare Technology Holdings, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 431 | 356 | 406 | 455 | 453 |
Cost of Revenue | |||||
Gross Profit | 418 | 342 | 395 | 440 | 437 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 301 | 427 | 418 | 457 | 451 |
Operating Profit | 131 | -71.9 | -11.9 | -2.01 | 2.11 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 130 | -66.7 | -18.3 | -9.59 | -3.04 |
Provision for Income Taxes | |||||
Net Income After Taxes | 124 | -68.7 | -20.1 | -8.63 | -4.77 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 126 | -68.8 | -20.6 | -9.57 | -5.07 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 126 | -68.8 | -20.6 | -9.57 | -5.07 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.074 | -0.078 | -0.041 | -0.014 | -0.006 |